Evidence map›Paper›PMID 38756789›Full record

ArticleChemical science2024

High-fidelity imaging of a tumour-associated lysosomal enzyme with an acceptor engineering-boosted near-infrared fluorescent probe.

Bin Feng, Feiyi Chu, Yanpeng Fang, Min Liu, Xueping Feng, Jie Dong, Fei Chen, Wenbin Zeng

Abstract read
In one paragraph

Article in Chemical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bin FengXiangya School of Pharmaceutical Sciences, Central South University Changsha 410013 China wbzeng@hotmail.com wbzeng@csu.edu.cn.
Feiyi ChuXiangya School of Pharmaceutical Sciences, Central South University Changsha 410013 China wbzeng@hotmail.com wbzeng@csu.edu.cn.
Yanpeng FangXiangya School of Pharmaceutical Sciences, Central South University Changsha 410013 China wbzeng@hotmail.com wbzeng@csu.edu.cn.
Min LiuXiangya School of Pharmaceutical Sciences, Central South University Changsha 410013 China wbzeng@hotmail.com wbzeng@csu.edu.cn.ORCID https://orcid.org/0000-0002-0194-4738
Xueping FengXiangya Hospital, Central South University Changsha 410013 China.ORCID https://orcid.org/0000-0003-0481-3853
Jie DongXiangya School of Pharmaceutical Sciences, Central South University Changsha 410013 China wbzeng@hotmail.com wbzeng@csu.edu.cn.
Fei ChenXiangya School of Pharmaceutical Sciences, Central South University Changsha 410013 China wbzeng@hotmail.com wbzeng@csu.edu.cn.ORCID https://orcid.org/0000-0002-7600-1945
Wenbin ZengXiangya School of Pharmaceutical Sciences, Central South University Changsha 410013 China wbzeng@hotmail.com wbzeng@csu.edu.cn.ORCID https://orcid.org/0000-0001-8314-9174

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To facilitate the understanding of the dynamic distribution and activity of lysosomal enzymes, it is highly desirable to develop high-fidelity near-infrared (NIR) activatable fluorescent probes. Here, we propose a general acceptor engineering strategy to construct NIR probes with lysosome-targeting capability. Upon isosteric replacement and additional functionalization, the β-gal-activatable probe OELyso-Gal exhibited excellent lysosome-targeting capability and favorable responsive performance to the enzyme of interest. Notably, the steric hindrance effect from acceptor engineering is modest, which renders the probe unprecedented affinity to enzymes. Upon the introduction of acceptor engineering, the lysosome-targeting probe became more sensitive to β-gal in cells and tissues, boosting the discrimination of high β-gal-expressing ovarian cancer tumours from low β-gal-expressing tissues. Furthermore, the superiority of OELyso-Gal was validated in real-time visualization of ovarian cancer in tumour-bearing mice. This elegant acceptor engineering strategy provides inspirational insights into the development of customized fluorescent probes for monitoring disease-associated biomarkers within subcellular organelles.

Identifiers

PMID38756789
PMCPMC11095509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.